ABSTRACT. This study was designed to examine @-nerve ment and maintenance of sympathic and neural crest-derived growth factor (NGF) levels in human cord blood by a two-sensory innervation in the periphery and of cholinergic innersite enzyme immunoassay using MAb 27/21 to mouse NGF vation in the CNS (3, 4). and to determine whether @-NGF levels show develop-A fruitful method in NGF research has been the introduction mental changes. Blood was collected at delivery from 61 of a sensitive two-site EIA with MAb 27/21 to mouse @-NGF newborns, 55 neonates appropriate for gestational age (46 that allows reliable determination of low levels of 0-NGF present term infants and 9 premature infants), 5 neonates small for in peripheral and CNS tissue (5, 6). Recently, the two-site EIA gestational age, and 1 neonate with congenital hydroceph-was applied to human adult sera and showed low levels of /3-alus. In addition, samples were collected from 2 microce-NGF (0.4 f 0.1 ng/mL) (7). The specific objectives of this study phalic children (microcephaly vera) aged 15 and 18 mo, 2 were to examine levels of P-NGF in human cord blood using the control children, and 4 healthy adults. Mean levels of NGF two-site EIA with the MAb 2712 1 to mouse (3-NGF and to in preterm infants ( n = 9; 13.7 f 8 pg/mL) were signifi-determine whether levels of 8-NGF show developmental cantly lower than levels in term infants ( n = 47; 21.2 f changes, as has been reported for P-NGF in animals (3). During 8.8 pg/mL; p = 0.034 by Mann-Whitney U test). There the course of this study, we were also interested in measuring /3-was no correlation between birth weight, length, head NGF levels in two children with cerebral malformation (microcircumference, and @-NGF levels. In microcephalic chil-cephaly vera) and comparing their results with those found in dren, NGF levels were low (8 pg/mL) compared with the neonatal period and in otherwise healthy children and adults. control infants' values (22 pg/mL). In adults, 8-NGF levels were higher and ranged between 238 and 292 pg/mL. Our MATERIALS AND METHODS study demonstrates that @-NGF levels can be assessed in human newborn sera using a two-site enzyme immunoassay Subjects. Between October and December 1992, levels of Pwith MAb 27/21 to mouse @-NGF, that @-NGF levels are NGF were measured from cord blood in 6 1 newborn infants. As extremely low in newborns compared with adults, that j3-emphasized above, we included 2 microcephalic children, 2 NGF levels seems to show developmental changes, and healthy children considered controls, and 4 healthy adults after that @-NGF levels may be used to assess NGF utilization obtaining parental and adult consent. This study was approved under normal and pathologic conditions such as cerebral by our institutional committee for ethics. malformations. (Pediatr Res 35: 637-639, 1994) Blood samples and pretreatment. Immediately after birth and after clamping the cord, placenta and cord were removed. Then Abbreviations 2.5 mL of blood were collected by cord puncture. In children and adults, 2.5 mL of blood were collected by venipuncture while NGF, nerve growth factor they were at rest. EIA, enzyme immunoassay Blood was collected in nonheparinized tubes containing 50 ccg of aprotinin. After I h of incubation at room temperature and subsequent incubation at 4°C overnight, cells and serum were separated by centrifugation (20 min). Plasma was stored at -20°C until assay. Substantial progress has been made in research on nerve H A . A two-site EIA for B-NGF, slightly modified from that ~wth factors since the initial discovery by Levi Montalcini and described by Soderstrom et al. (8), was used for the present study. ~mburger of the first neurotrophin, NGF (1). Apart from NGF, Immunoplates (black 96-well dishes; Nunc, Roskilde, en mark) urotrophins include brain-derived neurotrophic factor, neu-were coated with monoclonal anti-mouse P-NGF antibody 271 :rophin 3, neurotrophin 4, and neurotrophin 5. They have an 2 1 (obtained from Boehringer Mannheim Biochemica, Mannportant role in neuronal development and functioning of the heim, Germany). The stock solution of ~urified antibody 2712 1 rvous system (2). NGF, the best known factor (3), is a complex Was diluted in 0.05 M carbonate buffer (pH 9.6) to 0.3 Pg/mL. three subunits (a, 8, and y). The B subunit is entirely respon-Each well received 150 and the dishes were incubated at 37°C for the biologic effect. It is a dimer of two identical chains for 2 h. After washing them three times with wash buffer ( T~S -1 18 amino acids each. The genes for NGF and its receptor HCl, 50 mmol/L; NaCI, 200 mmol/L; CaC12, 10 m m o l /~; ~r i t o n ve been cloned and sequenced and are localized on the short X-100, 0.1 %; sodium azide, 0.05%; pH 7.0), the samples were n of human chromosome 1 and the long arm of human applied in a volume of 100 PL, and the plates were sealed and romosome 17, respectively. NGF is involved in the establish-incubated overnight at 4°C. TO serve as standards, samples of purified mouse P-NGF at 10-1000 pg/mL in the same buffer The plates were then washed three times in wash buffer at jex, France.
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gate (Boehringer Mannheim Biochemica; 4 U of enzyme activity/mL) was added (100 pL) at a dilution of 150 in sample buffer and incubated at 37'C for 4 h. After incubation, the immunoplates were washed three times with wash buffer. To start the enzyme activity, 200 pL of chlorophenol red 8-D-galactopyranoside diluted (2 mg/mL) in a substrate buffer [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 100 mmol/L; NaCl, 150 mmol/L; MgC12, 2 mmol/ L; sodium azide, 0.1 % (wt/vol); albumin, 1 % (wtlvol); pH 7.01 were added to each well and incubated for 2 h at room temperature.
Each immunoplate was introduced in a spectrophotometer (emission wavelength 570 nm). The EIA values for serum samples were determined from the regression line for the NGF standard incubated under similar conditions. EIA calibration. The EIA calibration was performed according to blood samples drawn from either neonates, children, or adults. Standard samples of purified mouse NGF (NGF 2.5 S, Boehringer Mannheim Biochemica) were incubated under conditions similar to those of blood samples. When blood samples from neonates or children were examined by the two-site EIA, samples of purified mouse NGF at concentrations of 2, 5, 10, 20, and 100 pg/mL were used; for adults, samples of 20, 50, 100, 200, 300,400, and 500 pg/mL were used. As shown in Figure 1 , the dose-response curve for the standard purified mouse NGF showed a linear relationship. Thus, the sensitivity of this two-site EIA under these conditions was routinely approximately 2 pg/ mL and is similar to that reported by Soderstrom et al. (8) .
Statistical analysis. The significance of the difference between means was determined by Mann-Whitney U Test and the correlation was determined by Pearson's method and multiple regression analysis.
RESULTS
(3-NGF levels are reported for newborn infants, infants, and adults in Table 1 .
Newborn Infants. Among the 6 1 infants included in this study, 55 were appropriate for gestational age and 5 were small for gestational age according to Lubchenco curves of fetal growth. One infant showed congenital hydrocephalus.
Appropriate for gestational age (n = 55). Mean levels of P-NGF in preterm infants (13.7 f 8 pg/mL) were significantly lower than those in term infants (2 1.2 f 8 pg/ mL) ( p = 0.034 by Mann-Whitney U test). When serum levels of P-NGF were plotted against gestational age, birth weight, birth length, and head circumference, no correlations were seen.
SmaN for gestational age (n = 5). Five term neonates (40 wk gestational age) rated as symmetric intrauterine growth retarded according to Lubchenco curves of fetal growth were included in this study. Their mean gestational age + SD was 38 f I wk, mean birth weight + SD 1934 f 3 14 g, mean birth length 43.2 + 2 cm, and mean head circumference f SD 29.6 + I cm. Their mean B-NGF level was 16.08 + 5 pg/mL (8.70-28.20 pg/mL), which was comparable to the values reported for infants appropriate for gestational age.
Congenital hydrocephalus. In one neonate, prenatal cerebral ultrasound showed dilated lateral and third ventricles. At birth (37 wk gestation), head circumference was 38.5 cm, weight was 3080 g, and length was 50 cm. Magnetic resonance imaging showed stenosis at the level of the sylvian aqueduct. The (3-NGF level was 2.28 pg/mL.
Infants. Two children, aged 15 and 18 mo, were severely microcephalic (36.9 and 40.5 cm, respectively). Microcephaly was determined to be "microcephaly vera." On magnetic resonance images, no cerebral lesions or cerebral malformations other than microcephaly were noted. P-NGF levels were 8 and 9 pg/mL for the 15-mo-old and the 18-mo-old, respectively.
The two other children, aged 14 and 16 mo, included were admitted to our unit for a mild respiratory disease. Their weight, length, and head circumference were within the normal ranges. P-NGF levels were 20.68 and 23.82 pg/mL for the 14-mo-old and the 16-mo-old, respectively.
Adults. The four adults included in this study were from the medical staff of the unit and were healthy. Their recorded P-NGF levels were as high as 292 pg/mL. DISCUSSION P-NGF from humans and mice have been characterized and found to be highly homologous (8) . Each monomer of both types is composed of 1 18 amino acids, but the amino acid sequence differs (8) . Until recently, because of the similarity between human and mouse NGF, MAb 2712 1 to mouse /3-NGF has been used in a two-site EIA to detect human NGF from various tissues (5) (6) (7) (8) . However, with the advent of new recombinant human anti-NGF, the detection of (3-NGF, especially at low levels, seems to be more reliable (9) . Nevertheless, the EIA performed at two sites using MAb 2712 1 has proved to be highly sensitive, allowing detection of NGF concentrations as low as 0.5 to 2.5 pg/mL (7). Sbderstrom et al. (8) demonstrated the ability of the two-site EIA using MAb 2712 1 to detect human NGF at the same sensitivity as mouse NGF. Furthermore, they demonstrated that MAb 27/21 to mouse 8-NGF was highly effective in blocking the biologic activity of both mouse and human recombinant NGF. It is worth mentioning that the two-site EIA used in our study does not differ significantly from that used by Siiderstrom et al., especially regarding incubation and washing procedures on which the high sensitivity of the EIA relies (8) .
Using the two-site EIA with antibody 2712 1 to mouse (3-NGF, we were able to detect very low levels of p-NGF in human neonatal cord blood compared with adult blood; our values in adults were comparable to those reported by Loragidos et a/. (7) . However, the presence of trace amounts of P-NGF in serum of neonates is unlikely to be of physiologic relevance. The serum levels of P-NGF probably reflect diffusion from target areas for innervation or release of NGF from other possible sources in the human body. Thus, the low levels of 8-NGF encountered in neonates may be caused by the low diffusion to the serum compartment. An alternative explanation would be interfering protein binding. However, the specificity of MAb 27/21 to 0-NGF is well documented and there is no cross-reactivity with other growth factors such as brain-derived neurotrophic factor, neurotrophins, epidermal growth factor, fibroblast growth factor, or insulin (7). Thus, the immunoreactivity in human serum established by the two-site EIA with MAb 27/21 more likely accounts for NGF. The detection of P-NGF in premature infants suggests that NGF is present during prenatal life. Indeed, other investigators have reported the detection of NGF mRNA and its complete nucleotide sequence in human fetal brain (cortices) as early as 15 wk of gestation and suggested that the trophic agent may play a role in cerebral development (10, 11) . NGF has also been detected in human amniotic fluid (12) and human placenta ( I 3). The difference noted in our study between levels of P-NGF in preterm and term infants and adults suggests a developmental appearance of NGF in humans, as has been described in the brain of animals (3). However, the difference noted between levels of preterm and term infants, although statistically significant, may be subject to discussion because it considers a small group of infants: It is noteworthy that infants with cerebral malformations (congenital hydrocephalus and microcephaly) showed the lowest values of 0-NGF. However, because of the small number of subjects, such data are difficult to interpret. Nevertheless, the low values encountered in those infants suggest reduced NGF activity or NGF utilization in association with reduced cerebral parenchyma. The same findings of low levels of P-NGF were reported in adult patients suffering from Parkinson's and Alzheimer's diseases (7) .
In conclusion, our study demonstrates that 8-NGF levels can be detected in human newborn sera using a two-site EIA with MAb 27/21 to mouse P-NGF; that these P-NGF levels are extremely low in newborns compared with adults; that P-NGF levels in sera seem to show developmental changes; and that P-NGF levels may be used to assess NGF utilization under normal and pathologic conditions such as cerebral malformations. However, more studies are warranted to assess the developmental changes of NGF levels and to confirm our data.
